CORDIS · 101079489 · HORIZON

TWINFLAG Twinning for Promoting Excellence, Ability and Knowledge to develop novel approaches for targeting inflammatory and degenerative age-related joint diseases

Coordinator: VALSTYBINIS MOKSLINIU TYRIMU INSTITUTAS INOVATYVIOS MEDICINOS CENTRAS (LT)

TWINFLAG is an advanced research consortium consisting of top-class institutions in the field of extracellular vesicles (EVs), flow cytometry and biobanking. The main objective of TWINFLag is to improve capacities of IMC in Lithuania, to implement the excellence in translational research of arthritis treatment and extracellular vesicle (EV)-based biomarker development, innovation and research management. For this purpose, the consortium gathered leading academic institutions in the field of biomedical sciences from Ireland (UCD) and Spain (INIBIC) which will seek to raise the research profile…

EU contribution
€1.5M
Total cost
€1.5M
Period
2023-01-01 → 2026-06-30
Framework
Horizon Europe (2021–2027)
Funding scheme
HORIZON-CSA
Call
HORIZON-WIDERA-2021-ACCESS-03
Status
SIGNED

About Horizon Europe (2021–2027)

Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.

EU contribution: €1.5M awarded to the consortium. The project runs over approximately 3.5 years from 2023-01-01 to 2026-06-30.

Full record on CORDIS — partners, deliverables, publications, news.

Open on cordis.europa.eu → Grant DOI ↗

Frequently asked questions

Who funds this research project?
This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-CSA funding scheme.
What is the EU contribution?
The European Commission contributes €1.5M toward a total project budget of €1.5M.
Which EU programme funds it?
The project is funded under Horizon Europe (2021–2027), call HORIZON-WIDERA-2021-ACCESS-03.
Who coordinates the project?
The project is coordinated by VALSTYBINIS MOKSLINIU TYRIMU INSTITUTAS INOVATYVIOS MEDICINOS CENTRAS (LT).
What is the project timeline?
The project runs from 2023-01-01 to 2026-06-30 — approximately 3.5 years.
Where can I find the full project record?
The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101079489.